Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
3.560
+0.070 (2.01%)
Nov 20, 2024, 4:00 PM EST - Market closed
Accolade Employees
Accolade had 2,400 employees as of February 29, 2024. The number of employees increased by 30 or 1.27% compared to the previous year.
Employees
2,400
Change (1Y)
30
Growth (1Y)
1.27%
Revenue / Employee
$183,762
Profits / Employee
-$33,374
Market Cap
286.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 748 |
Vanda Pharmaceuticals | 203 |
NeuroPace | 171 |
Nautilus Biotechnology | 167 |
Voyager Therapeutics | 162 |
iTeos Therapeutics | 157 |
Mersana Therapeutics | 123 |
Rezolute | 59 |
ACCD News
- 7 days ago - Accolade To Present at Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating - Business Wire
- 5 weeks ago - Accolade Welcomes Renalogic to Trusted Partner Ecosystem - PRNewsWire
- 6 weeks ago - Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30 - GuruFocus
- 6 weeks ago - Accolade Announces Results for Fiscal Second Quarter 2025 - GlobeNewsWire
- 6 weeks ago - Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 6 weeks ago - Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings - Benzinga